Robert Alexander Ingram's Net Worth
$102 Million
Who is Robert Alexander Ingram?
Robert Alexander Ingram has an estimated net worth of $102 Million. This is based on reported shares across multiple companies, which include REGENERON PHARMACEUTICALS INC, Valeant Pharmaceuticals International, Inc., CREE INC, BIOCRYST PHARMACEUTICALS INC, NORTEL NETWORKS CORP, PhaseBio Pharmaceuticals Inc, Novan, Inc., LOWES COMPANIES INC, Edwards Lifesciences Corp, Black Diamond Therapeutics, Inc., Clearside Biomedical, Inc., ALLERGAN INC, VALEANT PHARMACEUTICALS INTERNATIONAL, PHARMACEUTICAL PRODUCT DEVELOPMENT INC, QUINTILES TRANSNATIONAL CORP, G1 Therapeutics, Inc., WACHOVIA CORP NEW, and OSI PHARMACEUTICALS INC.
SEC CIK
Robert Alexander Ingram's CIK is 0001219890
Past Insider Trading and Trends
2008 was Robert Alexander Ingram's most active year for acquiring shares with 68 total transactions. Robert Alexander Ingram's most active month to acquire stocks was the month of August. 2007 was Robert Alexander Ingram's most active year for disposing of shares, totalling 98 transactions. Robert Alexander Ingram's most active month to dispose stocks was the month of February. 2016 saw Robert Alexander Ingram paying a total of $3,846,372.35 for 3,869,793 shares, this is the most they've acquired in one year. In 2018 Robert Alexander Ingram cashed out on 3,116,259 shares for a total of $40,454,042.57, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
REGENERON PHARMACEUTICALS INC (REGN) Snapshot price: $939
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.5K |
$404.60 | -$707,426.54 | 1.5K |
May 22 - May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Valeant Pharmaceuticals International, Inc. (BHC) Snapshot price: $8.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.36% | 2.12K |
$11.03 | $23,383.60 | 92.05K |
Mar 31
| |||
Form 4
| +1.65% | 1.46K |
$14.52 | $21,242.76 | 89.93K |
Dec 30
| |||
Form 4
| +0.99% | 865 |
$24.55 | $21,235.75 | 88.46K |
Sep 30
| |||
Form 4
| +1.25% | 1.08K |
$20.14 | $21,751.20 | 87.6K |
Jun 30
| |||
Form 4
| +23.97% | 16.73K |
—
|
—
| 86.52K |
Jun 17
| |||
Form 4
| +1.34% | 926 |
—
|
—
| 69.79K |
May 2
| |||
Form 4
| +0.35% | 239 |
—
|
—
| 68.87K |
Dec 31
| |||
Form 4
| +0.20% | 136 |
—
|
—
| 68.63K |
Sep 30
| |||
Form 4
| +0.16% | 109 |
—
|
—
| 68.49K |
Jun 30
| |||
Form 4
| +2.41% | 1.61K |
—
|
—
| 68.38K |
May 22
| |||
Form 4
| +0.18% | 122 |
—
|
—
| 66.78K |
Mar 31
| |||
Form 4
| +4.49% | 2.87K |
—
|
—
| 66.65K |
May 23
| |||
Form 4
| -1.97% | -1.28K |
$88.21 | -$112,820.59 | 63.79K |
Jun 4
| |||
Form 4
| -66.15% | -127.13K |
$90.81 | -$11,544,493.68 | 65.07K |
May 30
| |||
Form 4
| +2.68% | 5.02K |
—
|
—
| 192.19K |
May 24
| |||
Form 4
| +4.50% | 8.06K |
—
|
—
| 187.17K |
Jun 4
| |||
Form 4
| -19.95% | -44.63K |
—
|
—
| 179.11K |
May 30
| |||
Form 4
| +0.10% | 220 |
—
|
—
| 223.74K |
Dec 31
| |||
Form 4
| +0.13% | 277 |
—
|
—
| 220.69K |
Sep 30
| |||
Form 4
| +2.05% | 168 |
—
|
—
| 8.38K |
Sep 30
| |||
Form 4
| +0.06% | 127 |
—
|
—
| 220.41K |
Jun 30
| |||
Form 4
| +2.51% | 5.4K |
—
|
—
| 220.29K |
May 19
| |||
Form 4/A
| -4.34% | -9.87K |
$40.00 | -$394,880.00 | 217.72K |
Feb 28
| |||
Form 4/A
| +3.30% | 7.28K |
—
|
—
| 227.6K |
Dec 22
| |||
Form 4/A
|
∞
| 220.32K |
—
|
—
| 220.32K |
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
| -100.00% | -9.87K |
$40.00 | -$394,880.00 |
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
∞
| 217.58K |
—
|
—
| 217.58K |
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CREE INC (WOLF) Snapshot price: $26.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.99% | 760 |
$39.46 | $29,989.60 | 77.71K |
Oct 17
| |||
Form 4
| +5.48% | 4K |
$30.92 | $123,680.00 | 76.95K |
Aug 30
| |||
Form 4
| +0.90% | 648 |
$46.26 | $29,976.48 | 72.95K |
Aug 15
| |||
Form 4
| +1.07% | 764 |
$39.25 | $29,987.00 | 72.3K |
Apr 25
| |||
Form 4
| +1.18% | 833 |
$35.98 | $29,971.34 | 71.54K |
Jan 24
| |||
Form 4
| +1.04% | 731 |
$34.16 | $24,970.96 | 70.7K |
Oct 18
| |||
Form 4
| +11.17% | 7.03K |
—
|
—
| 69.97K |
Sep 1
| |||
Form 4
| +1.82% | 1.13K |
$22.21 | $24,986.25 | 62.94K |
Aug 23
| |||
Form 4
| +1.87% | 1.13K |
$22.07 | $24,983.24 | 61.82K |
Apr 26
| |||
Form 4
| +1.45% | 867 |
$28.83 | $24,995.61 | 60.68K |
Jan 25
| |||
Form 4
| +1.90% | 1.11K |
$22.41 | $24,987.15 | 59.82K |
Oct 19
| |||
Form 4
| +12.30% | 6.43K |
—
|
—
| 58.7K |
Sep 1
| |||
Form 4
| +2.41% | 1.23K |
$23.38 | $28,734.02 | 52.27K |
Aug 17
| |||
Form 4
| +2.21% | 1.1K |
$26.00 | $28,730.00 | 51.04K |
Apr 27
| |||
Form 4
| +2.24% | 1.09K |
$26.30 | $28,745.90 | 49.94K |
Jan 20
| |||
Form 4
|
—
|
0
|
$21.19 | -$48,592.50 | 48.85K |
Dec 1
| |||
Form 4
| +2.52% | 1.2K |
$23.96 | $28,728.04 | 48.85K |
Oct 21
| |||
Form 4
| +16.29% | 6.67K |
—
|
—
| 47.65K |
Sep 1
| |||
Form 4
| +2.79% | 1.11K |
$26.58 | $29,556.96 | 40.97K |
Aug 12
| |||
Form 4
| +2.08% | 811 |
$32.36 | $26,243.96 | 39.86K |
Apr 22
| |||
Form 4
| +2.02% | 775 |
$33.87 | $26,249.25 | 39.05K |
Jan 21
| |||
Form 4
| +2.58% | 962 |
$27.27 | $26,233.74 | 38.27K |
Oct 22
| |||
Form 4
| +12.83% | 4.24K |
—
|
—
| 37.31K |
Sep 2
| |||
Form 4
| +1.19% | 390 |
$44.81 | $17,475.90 | 33.07K |
Aug 13
| |||
Form 4
| +1.06% | 343 |
$51.01 | $17,496.43 | 32.68K |
Apr 23
| |||
Form 4
| +0.69% | 222 |
$67.30 | $14,940.60 | 32.34K |
Jan 22
| |||
Form 4
| +0.76% | 242 |
$61.75 | $14,943.50 | 32.11K |
Oct 23
| |||
Form 4
| +14.35% | 4K |
—
|
—
| 31.87K |
Sep 3
| |||
Form 4
| +0.92% | 255 |
$58.82 | $14,999.10 | 27.87K |
Aug 14
| |||
Form 4
| +0.97% | 265 |
$56.46 | $14,961.90 | 27.62K |
Apr 24
| |||
Form 4
| +1.36% | 367 |
$40.85 | $14,991.95 | 27.35K |
Jan 23
| |||
Form 4
| +1.96% | 518 |
$28.92 | $14,980.56 | 26.98K |
Oct 17
| |||
Form 4
| +17.80% | 4K |
—
|
—
| 26.47K |
Sep 4
| |||
Form 4
| +2.52% | 553 |
$27.11 | $14,991.83 | 22.47K |
Aug 8
| |||
Form 4
| +2.33% | 500 |
$29.97 | $14,985.00 | 21.91K |
Apr 18
| |||
Form 4
| +2.95% | 613 |
$24.44 | $14,981.72 | 21.41K |
Jan 18
| |||
Form 4
| +2.53% | 514 |
$24.30 | $12,490.20 | 20.8K |
Oct 19
| |||
Form 4
| +24.56% | 4K |
—
|
—
| 20.29K |
Sep 1
| |||
Form 4
| +2.31% | 367 |
$34.03 | $12,489.01 | 16.29K |
Aug 10
| |||
Form 4
| +2.02% | 315 |
$39.67 | $12,496.05 | 15.92K |
Apr 20
| |||
Form 4
| +1.52% | 233 |
$53.57 | $12,481.81 | 15.61K |
Jan 19
| |||
Form 4
| +1.65% | 249 |
$50.02 | $12,454.98 | 15.37K |
Oct 20
| |||
Form 4
| +49.39% | 5K |
—
|
—
| 15.12K |
Sep 1
| |||
Form 4
| +2.11% | 209 |
$59.78 | $12,494.02 | 10.12K |
Aug 11
| |||
Form 4
| +1.68% | 164 |
$76.19 | $12,495.16 | 9.91K |
Apr 21
| |||
Form 4
| +105.26% | 5K |
—
|
—
| 9.75K |
Sep 1
| |||
Form 4
| +26.67% | 1K |
$18.95 | $18,948.60 | 4.75K |
Mar 6
| |||
Form 4
|
∞
| 3.75K |
—
|
—
| 3.75K |
Dec 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIOCRYST PHARMACEUTICALS INC (BCRX) Snapshot price: $5.305
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.31% | 2.26K |
$8.85 | $19,992.15 | 100.2K |
Feb 28
| |||
Form 4
| +1.55% | 1.5K |
$13.36 | $19,999.92 | 97.94K |
Nov 30
| |||
Form 4
| +1.51% | 1.44K |
$13.90 | $19,988.20 | 96.44K |
Aug 31
| |||
Form 4
| +15.66% | 12.87K |
—
|
—
| 95K |
Jun 7
| |||
Form 4
| +2.60% | 2.08K |
$9.31 | $19,346.18 | 82.14K |
May 31
| |||
Form 4
| +1.43% | 1.13K |
$16.61 | $18,736.08 | 80.06K |
Feb 28
| |||
Form 4
| +2.01% | 1.55K |
$12.06 | $18,741.24 | 78.93K |
Nov 30
| |||
Form 4
| +1.54% | 1.18K |
$15.92 | $18,737.84 | 77.38K |
Aug 31
| |||
Form 4
| +1.58% | 1.19K |
$15.77 | $18,734.76 | 76.2K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| +2.37% | 1.74K |
$10.78 | $18,746.42 | 75.01K |
Feb 26
| |||
Form 4
| +5.27% | 3.67K |
$5.11 | $18,748.59 | 73.27K |
Nov 30
| |||
Form 4
| +6.94% | 4.52K |
$4.15 | $18,749.70 | 69.61K |
Aug 31
| |||
Form 4
| +6.85% | 4.17K |
$4.50 | $18,748.65 | 65.09K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| +11.43% | 6.25K |
$3.00 | $18,750.00 | 60.92K |
Mar 1
| |||
Form 4
| +13.68% | 6.58K |
$2.85 | $18,747.30 | 54.67K |
Dec 1
| |||
Form 4
| +71.20% | 20K |
$1.45 | $29,000.00 | 48.09K |
Nov 18
| |||
Form 4
| +28.74% | 6.27K |
$2.99 | $18,747.30 | 28.09K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +15.43% | 2.92K |
$6.43 | $18,749.88 | 21.82K |
Jun 1
| |||
Form 4
| +24.93% | 3.77K |
$4.97 | $18,746.84 | 18.9K |
Mar 1
| |||
Form 4
| +32.26% | 3.69K |
$5.08 | $18,745.20 | 15.13K |
Dec 1
| |||
Form 4
| +47.35% | 3.68K |
$5.10 | $18,747.60 | 11.44K |
Sep 1
| |||
Form 4
| +33.33% | 1.94K |
$5.15 | $9,996.15 | 7.76K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
| +37.95% | 1.6K |
$6.24 | $9,996.48 | 5.82K |
Mar 2
| |||
Form 4
| +73.49% | 1.79K |
$5.59 | $9,994.92 | 4.22K |
Dec 1
| |||
Form 4
|
∞
| 2.43K |
$4.11 | $9,999.63 | 2.43K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 5
| |||
No matching records found |
NORTEL NETWORKS CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |